Inmode Ltd. is an Israeli medical technology company that specializes in developing and commercializing energy-based aesthetic and medical treatment platforms. The company was founded in 2008 and is headquartered in Yokneam, Israel. Inmode's innovative platforms are designed to provide minimally invasive solutions for various aesthetic and medical procedures.
The company's flagship technology is called Radio Frequency (RF) energy, which is utilized in their advanced platforms. Inmode's products are used by medical professionals, including plastic surgeons, dermatologists, and gynecologists, to perform a wide range of procedures such as body contouring, skin tightening, facial rejuvenation, and women's health treatments.
Inmode's platforms are known for their versatility, precision, and safety. They offer a comprehensive suite of treatment options, allowing physicians to customize procedures based on patient needs and desired outcomes. The technology utilizes controlled heating and cooling mechanisms to target specific tissues while minimizing damage to surrounding areas, resulting in less downtime and faster recovery for patients.
In August 2019, Inmode went public on the NASDAQ stock exchange under the ticker symbol "INMD." The initial public offering (IPO) provided the company with additional capital to further expand its research and development efforts, commercialize new products, and enter new markets.
Since going public, Inmode has continued to innovate and expand its product portfolio. The company has a global presence, with a strong market presence in the United States and international markets. Inmode's cutting-edge technology and commitment to delivering effective and safe solutions have earned them recognition and trust among medical professionals worldwide.